NCT04164199 2026-04-14Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced MalignanciesBeOne MedicinesPhase 3 Active not recruiting404 enrolled
NCT06199973 2025-07-17Injection of SHR-A1811 Versus Physician Choiced Treatment in Patients With Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-fu, and IrinotecanSuzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 3 Active not recruiting130 enrolled